Edinburgh Research and Innovation: Licensing opportunities in Drug Discovery

Support for University staff

Home > Technology Licensing

Licensing opportunities in Drug Discovery

The following technologies are available to license in Drug Discovery at the University of Edinburgh.

p110 PI3 kinase mouse models

p110 PI3 kinase mouse models A series of PI3 kinase mouse models that enable the function of the p110 catalytic units to be investigated for target validation / pre-clinical drug discovery in cancer, fertility, diabetes and immunology... more info >

Peptide-based therapy of influenza virus infection

Peptide-based therapy of influenza virus infection A new generation of small peptides (6-12mers) has been developed with potent in vitro and in vivo activity against influenza A viruses. The peptides are capable of preventing and potentially treating influenza infection in vivo... more info >

Site Search

Latest Opportunity
Diagnostic aid to improve the early identification of skin cancer DERMOFIT is a diagnostic aid software that helps to correctly identify skin lesion types, leading to more effective diagnosis of skin cancer cases. view more licensing opportunities...

Biomedical Sciences &
Biotechnology Links

Biomedical Sciences & Biotechnology Research Expertise

Licensing Opportunities in Biomedical Sciences & Biotechnology
- Drug Discovery
- Medical Devices
- Reagents & Antibodies
- Therapeutics

Consultancy Services